Powered by Google Google ÜbersetzerGoogle Übersetzer
Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Latest Press Releases
View all
TimeHeadline
3m agoZacks Small-Cap Research Raises FatPipe (NASDAQ:FATN) Valuation from $6.00 to $6.40 per Share Following Preliminary Fiscal Fourth Quarter Business Update
4m agoMEDX HOLDINGS ANNOUNCES Q1 2026 HIGHLIGHTS, MULTI-CITY EXPANSION, AND CORPORATE ACTION TO REBRAND AS DAZED INC. (TICKER: DAZE)
4m agoVS Media Enters the AI Smart Living Sector to Explore New Growth Opportunities
30m agoGalderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch
31m agoSurface Transforms plc – in Administration, Sale of Business and Assets
Paradigm Biopharmaceuticals Ltd. logo

Paradigm Biopharmaceuticals Ltd.

About

0.17AUD+0.01 +3.03%
Closed • Updated at 17:06 GMT+00:00
Market Cap$61.93M
Volume1.55M
Beta1.60
RSI39.24
Gross Margin-161.09%
Health TechnologyPharmaceuticals: Generic

Paradigm Biopharmaceuticals Ltd. — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 30 2026
DSMB 20% Review Supports Phase 3, Moldova Activated
Apr 27 2026
March 2026 Quarterly Activities Report & Appendix 4C
Apr 27 2026
Upsized $14M Placement Extends Runway Post IA
Mar 31 2026
Paradigm Achieves 50% Patient Dosing in Phase 3
Feb 27 2026
Appendix 4D and Half Year Report

Community Chat

Ask AI

6ix6ixAIEvents